Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore. VolitionRX Ltd (VNRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived... Research Beam Model: Research Beam Product ID: 1995438 250 USD New
VolitionRX Ltd (VNRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

VolitionRX Ltd (VNRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : August   2017
  • Pages : 33
  • Publisher : GlobalData
 
 
 
Summary

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore.

VolitionRX Ltd (VNRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VolitionRX Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VolitionRX Ltd, Medical Devices Deals, 2011 to YTD 2017 8
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
VolitionRx Acquires Nucleosomics Technology Patent from Chroma Therapeutics 10
Partnerships 11
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 11
VolitionRX Extends Research Agreement with University of Bonn 12
Equity Offering 13
VolitionRx Raises USD14.1 Million in Public Offering of Shares 13
VolitionRx Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD10.6 Million 15
VolitionRx Completes Private Placement Of Shares For US$3 Million 17
Acquisition 18
ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 18
VolitionRX Ltd - Key Competitors 19
VolitionRX Ltd - Key Employees 20
VolitionRX Ltd - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update 22
Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update 24
Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update 25
Aug 11, 2016: VolitionRx Announces Second Quarter 2016 Financial Results and Business Update 26
May 13, 2016: VolitionRx Announces First Quarter 2016 Financial Results and Business Update 27
Mar 11, 2016: VolitionRx Announces Full Year 2015 Financial Results and Business Update 29
Corporate Communications 31
Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer 31
Apr 14, 2016: VolitionRx Appoints Louise Day as Chief Marketing and Communications Officer 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
VolitionRX Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VolitionRX Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VolitionRX Ltd, Medical Devices Deals, 2011 to YTD 2017 8
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
VolitionRx Acquires Nucleosomics Technology Patent from Chroma Therapeutics 10
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 11
VolitionRX Extends Research Agreement with University of Bonn 12
VolitionRx Raises USD14.1 Million in Public Offering of Shares 13
VolitionRx Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD10.6 Million 15
VolitionRx Completes Private Placement Of Shares For US$3 Million 17
ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 18
VolitionRX Ltd, Key Competitors 19
VolitionRX Ltd, Key Employees 20
VolitionRX Ltd, Subsidiaries 21
List of Figures
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VolitionRX Ltd, Medical Devices Deals, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter